To evaluate the effects of levobupivacaine on neuromuscular transmission and neuromuscular blockade produced by pancuronium in vitro.
Introduction
To explain the interaction between local anesthetics and neuromuscular blocking agents, several mechanisms have been described, including a presynaptic action by inhibition of acetylcholine release, a postsynaptic action due to stabilization of the postjunctional membrane, and interference with the phenomenon of excitation-contraction coupling of the muscle fiber [1] [2] [3] [4] . Although only high concentrations of local anesthetics can produce neuromuscular blockade, the interaction between these drugs and nondepolarizing neuromuscular blocking agents in particular is relevant in clinical practice, when both groups of drugs are used simultaneously and careful patient monitoring is required. Local anesthetics, especially amino amides, are drugs commonly used by different routes in anesthetic practice, either alone or in combination with general anesthesia [5] [6] [7] .
With the advent of stereoisomerism in local anesthetics, a major advance was made in pharmacological research mainly related to safety issues concerning drug toxicity. Levobupivacaine is a 100% (S-) pure enantiomer of racemic bupivacaine (S50-R50)
that has a lower lipid solubility, lower cardiotoxicity and neurotoxicity, a greater sensory blockade and less profound motor blockade than racemic bupivacaine 4, 6 . Pancuronium is a longacting aminosteroid, nondepolarizing neuromuscular blocking agent, used in prolonged surgeries and in intensive care units 1 .
It is fundamental to identify the interaction between these drugs, since the duration of their effects may be prolonged. The margin of safety of the neuromuscular junction may be impaired, leading to a higher risk of residual blockade and postoperative complications.
The aim of this study was to evaluate the effect of levobupivacaine on neuromuscular transmission in an experimental model and its influence on the neuromuscular block produced by pancuronium.
Methods
Procedures were performed in compliance with the ethical principles of animal experimentation adopted by the increase in approximately 85% of animals exposed simultaneously to LA and neuromuscular blocking agent, in comparison to nonexposed rats, with a significant difference, beta error= 20% (power = 80%), alpha error = 5%, and ratio of 1:1 between exposed and non-exposed animals, we achieved a sample size of five rats per group. The distribution of rats in the 3 groups was determined by lot: Group I -levobupivacaine (5 µg.mL -1 ); Group II -pancuronium (2 µg.mL -1 ); Group III -pancuronium (2 µg.mL -1 ) in a preparation previously exposed to levobupivacaine (5 µg.mL -1 ). In Group III, pancuronium was added to the preparation 30 minutes after the addition of levobupivacaine. The study drugs were provided by the Cristália Laboratory. Muscle response to indirect stimulation was recorded during 60 minutes after the addition of the drugs.
In the rat diaphragm, the effects of levobupivacaine on miniature end-plate potentials and membrane potentials were also studied.
To capture MEPPs, a glass microelectrode was implanted on or as close as possible to the region of the motor end-plate, with the aid of a micromanipulator (Leitz). Biopotentials were obtained by means 
Results
Levobupivacaine alone and used in the concentration studied in a rat phrenic nerve-diaphragm preparation did not cause a reduction in the amplitude of muscle response to indirect electrical stimulation. In preparations that had been previously exposed to levobupivacaine, the block produced by pancuronium was 90.2 ± 15.2%, with a significant difference (p=0.031), compared to the block produced by pancuronium alone (48.9% ± 9.8%). Membrane potentials did not show any significant changes in different time points of evaluation, ranging from 77.20 to 80.24 mV. The effects of levobupivacaine on miniature endplate potentials (MEPPs) were evidenced by a decrease greater than 60% in frequency and amplitude, at 30 minutes of exposure to the drug, followed by complete disappearance at 60 minutes.
Discussion
The current study conducted in a rat phrenic nervediaphragm preparation, showed that in the concentration studied levobupivacaine used alone, did not exert any effects on the neuromuscular junction. However, it potentiated the block produced by pancuronium.
The The interaction between local anesthetics and neuromuscular blocking agents is still not fully understood. The mechanism of action of these drugs seems to be multifactorial.
Presynaptic and postsynaptic events have been described [1] [2] [3] [4] 9, 10 . To identify the probable mechanism of interaction and potentiation of the block produced by pancuronium, in a preparation previously exposed to levobupivacaine, electrophysiological studies were conducted. In the evaluation of bioelectrical potentials, it was observed that levobupivacaine, in the concentration employed, did not alter the membrane potential of muscle fibers, which remained within normal limits (-85 mV). It was demonstrated that the drug has no depolarizing action on skeletal muscle fibers, although it prevents the conduction of action potentials 4 .
The presynaptic action of levobupivacaine and its interference in the processes of production or release of the mediator, has been studied through evaluation of the miniature end-plate potentials, also termed plate minipotentials. These are small potentials with an amplitude corresponds to the hundredth part of the end-plate potential. The function of these potentials is unknown but appears to be related to the maintenance of muscle trophism. These electrophysiological events detect a small, continuous and spontaneous release of a single acetylcholine quantum, ineffective to trigger an action potential, without the need of any neuronal electrical stimulus. As previously described 2-4 with other local anesthetics, it was also observed that levobupivacaine impairs neurotransmitter release, an event demonstrated by a progressive decrease in the frequency and amplitude of miniature endplate potentials, and decreased margin of safety of the neuromuscular junction. Therefore, these results may suggest that levobupivacaine has a presynaptic action in a manner similar to other local anesthetics, contributing to potentiation of the neuromuscular block produced by pancuronium.
Conclusion
Levobupivacaine potentiated the neuromuscular blockade produced by pancuronium, confirming a presynaptic action by a decrease in miniature endplate potentials.
